Clinical trial register · Spain

Clinical Trials in Oviedo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5882 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:19 UTC

5882

Studies in scope

all four open statuses

3093

Recruiting now

open to new participants

1126

Lead sponsors

across recruiting studies

Top sites

Barcelona 3238 Madrid 3054 Valencia 1203 Seville 1057 Málaga 761

Trials with a site in Oviedo

Status

Study

Lead sponsor

Phase

Enrol

Sites in Spain

Start

Not yet open

Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

NCT07441408Pulmonary Fibrosis

DrugAdmilparant

Bristol-Myers Squibb

Phase 3

2,380

Santander, Santiago de Compostela, Barcelona, Coslada, Madrid, Málaga, Oviedo

2026-12-16

Not yet open

Digital Patient-Reported Assessment in Older Adults With Acute Leukemia

NCT07597590Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia

Fundación para la Investigación Biosanitaria del Principado de Asturias

Not applicable

Oviedo

2026-12

Not yet open

Women in Action: A Multicomponent Intervention for Older Women

NCT07860424Sarcopenia, Physical Inactivity, Menopause, Healthy Aging

Universidad de Oviedo

Not applicable

214

Oviedo

2026-11

Not yet open

Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer

NCT07717099Metastatic Hormone-Sensitive Prostate Cance

DrugsRa223·Darolutamide

Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD

Phase 2

Barcelona, Las Palmas de Gran Canaria, Madrid, Oviedo, Santander, Santiago de Compostela, Valencia, Valladolid

2026-09

Recruiting

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

NCT07784270Obesity or Overweight, Diabetes Mellitus, Type 2

DrugLenbelintide

AstraZeneca

Phase 3

1,500

A Coruña, Alzira (Valencia), Barcelona, Castilleja de La Cuesta, Sevilla, Ferrol (A Coruña), Lleida, Málaga, Oviedo

2026-08-20

Recruiting

A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

NCT07775300Depressive Disorder, Major

DrugBrenipatide

Eli Lilly and Company

Phase 3

1,000

Barcelona, Centelles, Madrid, Oviedo, Salamanca, Seville, Zamora

2026-08-14

Recruiting

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

NCT07585266Gastrointestinal Stromal Neoplasms

DrugsVelzatinib·Imatinib

GlaxoSmithKline

Phase 3

800

BaracaldoVizcaya, Barcelona, Madrid, Oviedo, Seville, Valencia, Zaragoza

2026-07-27

Recruiting

A Post-Market Assessment of the Safety and Performance of the TriClip™ System

NCT07586995Tricuspid Regurgitation (TR)

Abbott Medical Devices

Observational

1,000

Oviedo, Barcelona

2026-07-02

Not yet open

TNT With FLOT/Durvalumab Plus Post-OP Durvalumab for Resectable Gastroesophageal Adenocarcinoma

NCT07507968Esophagogastric Adenocarcinoma

DrugDurvalumab

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2

101

Badalona, Barcelona, Granada, Jaén, Málaga, Oviedo, Pamplona, Valencia

2026-07-01

Recruiting

Pridopidine Phase 3 Study in Huntington's Disease

NCT07609108Huntington Disease

DrugPridopidine

Prilenia

Phase 3

400

Barakaldo, Barcelona, Madrid, Oviedo, Seville

2026-07-01

Recruiting

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

NCT07504458Acute Promyelocytic Leukemia (APL), Acute Promyelocytic Leukaemia, Acute Promyelocytic Leukemia With PML-RARA, Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA

DrugsArsenic Trioxide·ATRA

Quetzal Therapeutics

Phase 3

150

Palma de Mallorca, Badalona, Barcelona, Cáceres, Málaga, Oviedo, Valencia

2026-06-08

Recruiting

MAVRiC Studies 2L Treatment With AV in Patients With CLL/SLL Who Have Relapsed After a Course of BTKi + BCL2i Combination, With or Without Obinutuzumab

NCT07024706Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL)

DrugsAcalabrutinib·Venclexta·Venetoclax

AstraZeneca

Phase 2

Barcelona, Granada, Madrid, Majadahonda, Oviedo, Seville, Zaragoza

2026-06-04

Recruiting

Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material

NCT07403825Macular Degeneration, Age Related

DrugsVabysmo·Faricimab

Biobizkaia Health Research Institute

Phase 4

100

Córdoba, Bilbao, Valladolid, Albacete, Barcelona, Madrid, Majadahonda, Oviedo

2026-05-25

Recruiting

A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)

NCT07570173B-cell Acute Lymphoblastic Leukemia

DrugsAvtozma·Tyenne·Siltuximab·MK-1045

Merck Sharp & Dohme LLC

Phase 2/3

340

Badalona, Pamplona, Oviedo, Madrid, Salamanca

2026-05-18

Not yet open

Identification of Modifiable Sleep-related Factors in Patients With Systemic Lupus Erythematosus.

NCT07483541Lupus Erythematosus

Investigación en Hemofilia y Fisioterapia

Observational

250

Oviedo

2026-05-05

Not yet open

Effectiveness of an Educational Program for Pain Management in Patients With Hemophilic Arthropathy

NCT07420387Hemophilia

Investigación en Hemofilia y Fisioterapia

Not applicable

Oviedo

2026-03-27

Not yet open

Incidence of Ultrasonographically Detected Articular Damage in Initially Healthy Joints of Patients With Hemophilia A Receiving Prophylactic Treatment With Emicizumab

NCT07420348Hemophilia

Investigación en Hemofilia y Fisioterapia

Observational

Oviedo

2026-02-27

Not yet open

Clinical and Psychosocial Factors Associated With Physical Activity Level in Adults With Marfan Syndrome

NCT07419386Marfan Syndrome

University of Oviedo

Observational

118

Oviedo

2026-02-22

Recruiting

Physical Activity, Fatigue, Social Support, and Psychological Well-Being in Women With Primary Hypothyroidism

NCT07408765Hypothyroidism Primary

University of Oviedo

Observational

Oviedo

2026-02-16

Active, closed

Association Between Racket Stiffness and Lateral Epicondylalgia in Tennis Players

NCT07406802Tennis Elbow

University of Oviedo

Observational

207

Oviedo

2026-02-13

Not yet open

Residual Athletic Identity, Body Image, and Emotional Symptoms in Retired Rhythmic Gymnasts

NCT07408752Retirement

University of Oviedo

Observational

100

Oviedo

2026-02-12

Active, closed

Association Between Weekly Strength Training Load and Perceived Physical Performance in Non-Professional Soccer Players

NCT07408739Athletic Injuries

University of Oviedo

Observational

154

Oviedo

2026-02-12

Active, closed

Influence of Training Surface and Mechanical Load on the Prevalence of Patellofemoral Pain in Recreational Runners

NCT07408700Patello Femoral Pain Syndrome

University of Oviedo

Observational

134

Oviedo

2026-02-12

Recruiting

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

NCT07412756Depressive Disorder, Major

DrugBrenipatide

Eli Lilly and Company

Phase 3

1,000

Barcelona, Madrid, Oviedo, Salamanca, Zamora

2026-02-09

Active, closed

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

NCT07284901Obesity With Diabetes, Overweight With Diabetes

DrugRibupatide

Kailera

Phase 3

1,270

Ferrol, Seville, Villamartín, Barcelona, Oviedo, Castilleja de la Cuesta, Madrid, Valencia

2026-01-12

Recruiting

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

NCT07227454Depressive Disorder, Major

DrugsEsketamine·Midazolam

Janssen Research & Development, LLC

Phase 3

258

Barcelona, Esplugues de Llobregat, Madrid, Manresa, Oviedo, Pamplona, Sabadell, Santander

2026-01-08

By invitation

A Novel Adaptation of the Unified Protocol (UP) as a Transdiagnostic Intervention for Emotional Disorders in Addictive Behaviors

NCT07738081Addictive Behaviors, Emotion Regulation

University of Oviedo

Not applicable

Oviedo

2026-01-05

Recruiting

PMCF Study Fortilink-TS Ti

NCT07834736Degenerative Disc Disease Lumbar, Spondylolisthesis, Grade 1

BAAT Medical Products B.V.

Observational

Madrid, Oviedo

2026-01-01

Active, closed

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

NCT07284875Obesity, Overweight

DrugRibupatide

Kailera

Phase 3

2,530

Ferrol, Seville, Villamartín, Barcelona, Oviedo, Castilleja de la Cuesta, Madrid, Valencia

2025-12-18

Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

NCT07185997Non-Small-Cell Lung Cancer, Metastatic Non-Small-Cell Lung Cancer, Advanced Non-Small-Cell Lung Cancer, EGFR P-Loop and Alpha C-Helix Compressing

DrugFurmonertinib

ArriVent BioPharma, Inc.

Phase 3

480

Palma, Barcelona, Málaga, Oviedo, Valencia

2025-12-17

Recruiting

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

NCT07214779Ovarian Cancer

DrugINCB123667

Incyte Corporation

Phase 3

466

Alava, Badalona, Barcelona, Madrid, Málaga, Oviedo, Palma, Sabadell

2025-12-09

Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

NCT07218926Gastrointestinal Neoplasms

DrugsIDRX-42·Sunitinib

GlaxoSmithKline

Phase 3

450

Barcelona, Madrid, Oviedo, Seville, Valencia, Zaragoza

2025-12-03

Recruiting

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

NCT07211958Acute Myeloid Leukemias

DrugRevumenib

Syndax Pharmaceuticals

Phase 3

468

Badalona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Santander, Oviedo, Alicante, Barcelona, Burgos

2025-11-25

Recruiting

Nutritional Management of the Patient With Type 2 Diabetes at Nutritional Risk or With Malnutrition in Clinical Practice

NCT07252765Type 2 Diabetes Mellitus (T2DM), Malnutrition, Malnourishment, Drug-Induced Diabetes

Outcomes'10

Observational

334

Santander, Huelva, Las Palmas de Gran Canaria, Madrid, Málaga, Oviedo, Seville, Valencia

2025-11-20

Recruiting

A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis

NCT07201051Bronchiectasis

DrugGSK3862995B

GlaxoSmithKline

Phase 2

363

Barcelona, Lleida, Madrid, MErida Badajoz, Oviedo, Valencia

2025-10-30

Recruiting

Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome

NCT07168434IBS (Irritable Bowel Syndrome), IBS-D (Diarrhea-predominant), IBS, Mixed Symptoms

DrugSaccharomyces boulardii

Biocodex

Phase 3

406

Barcelona, León, Madrid, Marbella, Málaga, Oviedo

2025-10-22

Recruiting

A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy

NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Stemline Therapeutics, Inc.

Observational

140

Albacete, Alicante, Badalona, Burgos, Cáceres, Córdoba, Madrid, Oviedo

2025-10-17

Recruiting

Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis

NCT07465848Lung Cancer (Diagnosis), Health Adult Subjects, Patient

Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)

Not applicable

1,200

Elche, Barcelona, Santander, Madrid, Oviedo, Toledo, Valencia

2025-10-08

Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

NCT06989437Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma

DrugPonsegromab

Pfizer

Phase 2/3

982

Barcelona, Madrid, Oviedo, Málaga

2025-10-03

Recruiting

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

NCT07007312Acute Myeloid Leukemia (AML)

DrugsZiftomenib·Ara-C·Daunorubicin·Venclexta

Kura Oncology, Inc.

Phase 3

1,300

Seville, Zaragoza, Burgos, Salamanca, Albacete, Madrid, Oviedo, Valencia

2025-09-26

Recruiting

General Anesthesia vs Conscious Sedation for Radial Endobronchial Ultrasound

NCT06950515Lung Cancers, Peripheral Pulmonary Nodules

Institut universitaire de cardiologie et de pneumologie de Québec, University Laval

Not applicable

306

Oviedo

2025-09-25

Recruiting

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

NCT07053423Chronic Obstructive Pulmonary Disease

DrugDupilumab

Sanofi

Phase 4

218

Santander, Barcelona, Pozuelo de Alarcón, Oviedo, Madrid

2025-09-22

Active, closed

Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer.

NCT06992609Small Cell Lung Carcinoma

DrugDurvalumab

AstraZeneca

Phase 3

A Coruña, Badajoz, Barakaldo, Barcelona, Madrid, Málaga, Oviedo, Santander

2025-09-15

Not yet open

5-fluorouracil Plus Panitumumab (Anti-EGFR) and Sotorasib (KRAS G12C Inhibitor) in First-line Treatment of Patients Non-eligible for a Doublet/Triplet Chemotherapy With Advanced Unresectab

NCT07124884Colorectal Carcinoma, KRAS G12C Mutation, Unresectable Colorectal Cancer

Federation Francophone de Cancerologie Digestive

Phase 2

300

Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Oviedo, Pamplona, Salamanca, San Carlos

2025-08-31

Recruiting

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

NCT07058077Heterozygous Familial Hypercholesterolemia (HeFH)

DrugsEnlicitide·Enlicitide Decanoate

Merck Sharp & Dohme LLC

Phase 2/3

153

Oviedo, Santiago de Compostela, Pamplona

2025-08-21

By invitation

Impact of Specific Oligomeric Supplementation in Oncologic Patients Undergoing Radiotherapy With Malnutrition or at Risk.

NCT07035132Malnutrition in Elderly, Oncological Patients, Digestive Disorders

Outcomes'10

Observational

132

Alicante, Madrid, Oviedo, Palma de Mallorca

2025-08-15

Recruiting

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

NCT06952803Prostate Cancer

DrugsPrednisolone/prednisone·Saruparib·Abiraterone

AstraZeneca

Phase 3

700

Barcelona, Girona, Madrid, Majadahonda, Málaga, Oviedo, Sabadell, Santander

2025-08-06

Recruiting

Study to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)

NCT06709339Polypoidal Choroidal Vasculopathy

DrugsVabysmo·Faricimab

Association for Innovation and Biomedical Research on Light and Image

Phase 4

120

Barcelona, Madrid, Oviedo, Valencia

2025-08-06

Recruiting

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

NCT07044336Endometrial Cancer, Malignant Solid Tumour

DrugsAdriamycin·Taxol·Doxorubicin·Paclitaxel

AstraZeneca

Phase 3

800

Badalona, Barcelona, Córdoba, El Palmar (Murcia), L'Hospitalet de Llobregat, Madrid, Málaga, Oviedo

2025-08-01

Recruiting

Association of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With Hemophilia

NCT07099313Hemophilia

Investigación en Hemofilia y Fisioterapia

Observational

114

Oviedo

2025-07-31

Recruiting

Multidimensional Assessment of Chronic Pain in Severe Haemophilia A

NCT07096349Hemophilia A Without Inhibitor

Investigación en Hemofilia y Fisioterapia

Observational

109

Oviedo

2025-07-30

Recruiting

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)

DrugsZanzalintinib·Everolimus

Exelixis

Phase 2/3

440

Barcelona, Madrid, Murcia, Oviedo, Santander, Santiago de Compostela, Seville, Valencia

2025-07-21

Recruiting

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

NCT07069712Gastroesophageal Adenocarcinoma

DrugsSonesitatug Vedotin·Calcium folinate·Rilvegostomig·Trastuzumab deruxtecan

AstraZeneca

Phase 2

100

Barcelona, Elche, Madrid, Málaga, Ourense, Oviedo, Santander, Valencia

2025-07-17

Recruiting

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

NCT06997497Colon Adenocarcinoma, Rectal Adenocarcinoma

DrugsLeucovorin/levofolinate calcium·Bevacizumab biosimilar·Calderasib·Mvasi

Merck Sharp & Dohme LLC

Phase 3

477

Badalona, Santander, Las Palmas de Gran Canaria, Oviedo, Barcelona, Madrid, Seville, Valencia

2025-07-16

Recruiting

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

NCT07284121Lung Cancer, Hepatocellular Carcinoma

DrugsTecentriq·Atezolizumab

Hoffmann-La Roche

Observational

700

Almería, Palma de Mallorca, Manresa, Puerto Real, Alcázar de San Juan, Santiago de Compostela, Oviedo, Reus

2025-07-15

Recruiting

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

NCT06937099Crohn's Disease, Obesity or Overweight

DrugsMirikizumab·Tirzepatide

Eli Lilly and Company

Phase 3

290

Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia

2025-06-26

Recruiting

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

NCT06937086Ulcerative Colitis, Obesity or Overweight

DrugsMirikizumab·Tirzepatide

Eli Lilly and Company

Phase 3

350

Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia

2025-06-26

Recruiting

Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors

NCT06878664Grade1-2 Advanced Midgut Neuroendocrine Tumors (NETs)

DrugsAmino acid·Lanreotide·Octreotide LAR·Lutathera

Grupo Espanol de Tumores Neuroendocrinos

Phase 3

166

Barcelona, L'Hospitalet de Llobregat, Burgos, Granada, Madrid, Oviedo, Seville, Valencia

2025-06-12

Recruiting

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

NCT06784752Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)

DrugOctreotide LAR

Novartis Pharmaceuticals

Phase 3

240

L'Hospitalet de Llobregat, Oviedo, Barcelona, Madrid, Salamanca

2025-05-30

Recruiting

Surgical vs Transcatheter Aortic Valve Replacement in YOUNG Patients

NCT06861361Symptomatic Severe Aortic Stenosis

Ceric Sàrl

Not applicable

1,180

Oviedo, Valladolid

2025-05-15

Not yet open

Physical Activity in Patients With Systemic Lupus Erythematosus

NCT06919250Lupus Erythematosus, Systemic

University of Oviedo

Observational

Oviedo

2025-03-31

Recruiting

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

NCT06644781Esophageal Squamous Cell Carcinoma

DrugsIfinatamab Deruxtecan·Irinotecan·Docetaxel·Paclitaxel

Daiichi Sankyo

Phase 3

510

Barcelona, Burgos, Elche, L'Hospitalet de Llobregat, Madrid, Málaga, Ourense, Oviedo

2025-03-27

Active, closed

Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)

NCT06726265Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

DrugsEfti·Pemetrexed·Keytruda·Paclitaxel

Immutep S.A.S.

Phase 3

756

Badalona, Barcelona, Córdoba, Madrid, Málaga, Oviedo, Sabadell, Seville

2025-03-21

Not yet open

Efficacy of Shock Wave Therapy in Post-Stroke Muscle Spasticity Management

NCT06815328Stroke, Spasticity, Post-stroke, Muscle Hypertonia

University of Oviedo

Not applicable

Oviedo

2025-03-15

Recruiting

Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke

NCT05930145Stroke, Thrombectomy, Arterial Occlusive Diseases

Fundación EPIC

Not applicable

200

Barakaldo, Oviedo, Valladolid

2025-03-14

Recruiting

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

NCT06788756Acute Myeloid Leukaemia (AML)

DrugCytarabine

Moleculin Biotech, Inc.

Phase 2/3

312

Barcelona, Oviedo, Madrid, Valencia

2025-03-12

Recruiting

Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM)

NCT06908785Cirrhosis, Liver

Instituto de Investigación Marqués de Valdecilla

Observational

330

Santander, Alicante, Barcelona, Bilbao, Burgos, Madrid, Oviedo, Toledo

2025-03-01

Recruiting

A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer

NCT06567782Neoplasms, Colon

DrugsCapeox·Dostarlimab

GlaxoSmithKline

Phase 2

120

Barcelona, Madrid, Oviedo, Valencia

2025-02-18

Recruiting

Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

NCT06641414Higher-risk Myelodysplastic Syndrome

DrugsLisaftoclax·Azacitidine

Ascentage Pharma Group Inc.

Phase 3

490

Badalona, Barcelona, Cáceres, Girona, Madrid, Málaga, Ourense, Oviedo

2025-01-22

Recruiting

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT06588478Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

DrugPirtobrutinib

Loxo Oncology, Inc.

Phase 2

249

Barcelona, L'Hospitalet Del Llobregat, Madrid, Majadahonda, Marbella, Oviedo, Salamanca, Santander

2025-01-03

Active, closed

A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)

NCT06687369Non Squamous Non Small Cell Lung Cancer

DrugsEU sourced Keytruda·US-sourced Keytruda·Pemetrexed·Cisplatin

mAbxience Research S.L.

Phase 3

726

A Coruña, Barcelona, Madrid, Málaga, Murcia, Oviedo, Palma de Mallorca, Pontevedra

2024-12-30

Recruiting

A Mobile App to Reduce and/or Quit Cannabis Use

NCT06733792Cannabis Dependence

Alba González-Roz, PhD

Not applicable

120

Oviedo

2024-12-13

Recruiting

Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression

NCT06180356Ovarian Cancer, Oligometastatic Disease, Serous Ovarian Tumor

DrugNiraparib

MedSIR

Phase 2

A Coruña, Barakaldo, Barcelona, Girona, Jaén, Madrid, Málaga, Oviedo

2024-12-03

Active, closed

Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine

NCT06543914Migraine

AbbVie

Observational

1,314

Málaga, L'Hospitalet de Llobregat, Leganés, Majadahonda, Oviedo, Seville, Barcelona, Madrid

2024-11-26

Recruiting

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

NCT06532006Gastroesophageal-junction Cancer, Monoclonal Antibody, Gastric Cancer, HER2-positive Gastric Cancer

DrugsHLX22·Trastuzumab·Capecitabine·Oxaliplatin

Shanghai Henlius Biotech

Phase 3

550

Barcelona, Madrid, Majadahonda, Oviedo, Seville, Valencia, Vigo

2024-11-22

Active, closed

A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment

NCT06668805Noonan Syndrome

DrugVosoritide

BioMarin Pharmaceutical

Phase 2

Santiago de Compostela, Oviedo

2024-11-22

Active, closed

Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain

NCT06415175Atopic Dermatitis

DrugDupilumab

Sanofi

Observational

143

Santiago de Compostela, Esplugues de Llobregat, Oviedo, Seville, Alicante, Barcelona, Madrid, Málaga

2024-11-14

Active, closed

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

NCT06596694Gastrointestinal Cancer

DrugPatritumab deruxtecan

Merck Sharp & Dohme LLC

Phase 1/2

180

Oviedo, Barcelona, Madrid

2024-11-03

Recruiting

DRUG RELEASING BALL vs. PHARMACOACTIVE STENT IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY) IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY)

NCT06448637Coronary Artery Disease

Fundación EPIC

Not applicable

Barcelona, Gijón, Huelva, León, Lugo, Mérida, Oviedo, Pontevedra

2024-10-23

Active, closed

A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma

NCT06190951Melanoma

DrugsFianlimab·Cemiplimab

Regeneron Pharmaceuticals

Phase 2

151

Granada, Málaga, Palma, Badalona, Barcelona, El Palmar, Oviedo, Madrid

2024-09-18

Recruiting

Sacituzumab govitEcan in THYroid Cancers

NCT06235216Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer

DrugSacituzumab Govitecan

Grupo Espanol de Tumores Neuroendocrinos

Phase 2

Barcelona, Ferrol, Hospitalet de Llobregat (Barcelona), Madrid, Murcia, Oviedo, Santander, Zaragoza

2024-09-13

Recruiting

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

NCT06379789Hemophilia B

Regeneron Pharmaceuticals

Phase 1/2

130

Seville, A Coruña, El Palmar, Oviedo, Barcelona, Madrid, Valencia, Zaragoza

2024-09-11

Active, closed

Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome

NCT06315751Tourette Syndrome

Noema Pharma AG

Phase 2

164

Barcelona, Burgos, Madrid, Oviedo, Sant Cugat del Vallès, Seville

2024-09-10

Active, closed

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

NCT06311721Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

DrugsABP 234·Keytruda·Pembrolizumab

Amgen

Phase 3

315

Alicante, Barcelona, Jaén, Madrid, Mataró, Málaga, Oviedo, Seville

2024-09-09

Recruiting

Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter

NCT06370182Acute Ischemic Stroke From Large Vessel Occlusion

Anaconda Biomed S.L.

Not applicable

327

Barcelona, Madrid, Murcia, Oviedo

2024-09-09

Recruiting

Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT06544785Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

DrugsZanubrutinib Product·Zanubrutinib·Obinutuzumab

PETHEMA Foundation

Phase 2

106

Alicante, Barcelona, Córdoba, Las Palmas de Gran Canaria, Madrid, Marbella, Málaga, Oviedo

2024-09-02

Recruiting

Abbott Structural Heart Device Registry

NCT06590467Heart Diseases, ASD - Atrial Septal Defect, VSD - Muscular Ventricular Septal Defect, PFO - Patent Foramen Ovale

Abbott Medical Devices

Observational

2,500

Esplugues de Llobregat, Oviedo, Seville, Madrid

2024-08-21

Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

NCT06549595Untreated Follicular Lymphoma

DrugsSurovatamig·R-Chop

AstraZeneca

Phase 3

1,018

Barcelona, El Palmar, Girona, Las Palmas de Gran Canaria, Madrid, Oviedo, Pamplona, Santander

2024-08-07

Active, closed

A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work

NCT06290128Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic

DrugRiliprubart

Sanofi

Phase 3

109

Santiago de Compostela, Barcelona, Bilbao, Majadahonda, Pamplona, Oviedo, Sabadell, Santa Cruz de Tenerife

2024-07-12

Recruiting

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

NCT06463587Generalized Myasthenia Gravis

DrugCladribine

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Phase 3

264

Badalona, Córdoba, Oviedo, Barcelona, Valencia

2024-06-25

Recruiting

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

NCT06428409Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer

DrugsSacituzumab tirumotecan·Fluorouracil·Leucovorin·Adrucil

Merck Sharp & Dohme LLC

Phase 1/2

220

Madrid, Oviedo, Barcelona

2024-06-20

Active, closed

A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)

NCT06472076Lung Cancer, Non-Small Cell

DrugsBelrestotug·Dostarlimab·Pembrolizumab

GlaxoSmithKline

Phase 3

A Coruña, Aravaca, BaracaldoVizcaya, Barcelona, Jaén, Las Palmas de Gran Canar, Madrid, Oviedo

2024-06-10

Active, closed

Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5

NCT06284122Follicular Lymphoma

DrugsBendamustin·Mosunetuzumab·Vincrystine·Obinutuzumab

The Lymphoma Academic Research Organisation

Phase 3

790

Albacete, Barcelona, Las Palmas de Gran Canaria, Lleida, Madrid, Marbella, Oviedo, Salamanca

2024-06-07

Recruiting

Immunological Characteristics of Preclinical IBD

NCT05698745Crohn Disease, Ulcerative Colitis, IBD

Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa

Observational

450

Santiago de Compostela, Badalona, Manresa, Terrassa, Donostia / San Sebastian, Vigo, Gijón, Oviedo

2024-06-01

Recruiting

CHOP Plus Mosunetuzumab as First Line in Patients With Richter´s Syndrome: a Phase II Study of the Spanish Group of CLL

NCT06926205Richter Syndrome

DrugMosunetuzumab

GELLC (Grupo Español de Leucemia Linfocítica Crónica)

Phase 2

Barcelona, L'Hospitalet de Llobregat, Santander, Las Palmas de Gran Canaria, Madrid, Murcia, Marbella, Oviedo

2024-05-15

Active, closed

A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)

NCT06356311Gastroesophageal Cancer

DrugsTrifluridine/Tipiracil·Sacituzumab tirumotecan·Irinotecan·Docetaxel

Merck Sharp & Dohme LLC

Phase 3

473

Santander, A Coruña, Pamplona, Oviedo, Barcelona, Madrid

2024-05-03

Active, closed

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT06383390Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD)

DrugRetatrutide

Eli Lilly and Company

Phase 3

10,000

A Coruña, Almería, Alzira, Barcelona, Ferrol, Málaga, Oviedo, Palma de Mallorca

2024-04-30

Active, closed

A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

NCT06346067Advanced or Metastatic NRAS-mutant Melanoma

DrugsNaporafenib·Temodar·Dacarbazine·Trametinib

Erasca, Inc.

Phase 3

Barcelona, Madrid, Oviedo

2024-04-29

Recruiting

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

NCT05980806Myelofibrosis, Moderate Thrombocytopenia, Mild Thrombocytopenia

DrugsMomelotinib·Pacritinib·Selinexor·Ruxolitinib

Karyopharm Therapeutics Inc

Phase 2

Badalona, El Palmar, Oviedo, Cáceres, Girona, Las Palmas de Gran Canaria, Salamanca, Valencia

2024-04-22

Active, closed

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

NCT06329401Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, Pulmonary Fibrosis Secondary to Systemic Sclerosis, Pulmonary Fibrosis, Interstitial Lung Disease

DrugPirfenidone

Avalyn Pharma Inc.

Phase 2

398

Granada, Barcelona, Santander, Madrid, Málaga, Oviedo, Seville, Cadiz

2024-04-03

Active, closed

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

NCT06291376Immunoglobulin A Nephropathy, IgAN

DrugRavulizumab

Alexion Pharmaceuticals, Inc.

Phase 3

584

A Coruña, Alcalá de Henares, Lleida, Madrid, Málaga, Murcia, Oviedo, Seville

2024-03-29

Active, closed

A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer

NCT06348199Non-small Cell Lung Cancer Stage IV

DrugsKeytruda·Pembrolizumab

Samsung Bioepis Co., Ltd.

Phase 3

555

Leganés, Málaga, Ourense, Oviedo, Santiago de Compostela, Seville, Valencia

2024-03-12

Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT06001788AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar

DrugsXospata·Granulocyte Colony-Stimulating Factor·Ziftomenib·Idarubicin

Kura Oncology, Inc.

Phase 1

171

Barcelona, Oviedo, Seville, Valencia

2024-02-22

Active, closed

Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.

NCT05930275Crohn's Disease

AbbVie

Observational

1,200

Sant Joan Despí, Jerez de la Frontera, Córdoba, Las Palmas de Gran Canaria, Leganés, Oviedo, Galdakao, Barcelona

2024-02-19

Active, closed

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

NCT05853575Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung

DrugAdagrasib

Mirati Therapeutics Inc.

Phase 2

200

Santiago de Compostela, Málaga, Palma de Mallorca, Oviedo, Barcelona, Madrid, Seville, Valencia

2024-02-01

Not yet open

First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma

NCT06097455Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma

Fundacion Clinic per a la Recerca Biomédica

Early Phase 1

Santiago de Compostela, Barcelona, Madrid, Murcia, Oviedo, Palma de Mallorca, Salamanca

2024-01-15

Recruiting

Prospective, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Endovascular Treatment in Patients With Cerebral Aneurysms Using P64 and P48 Flow-Diverter Stents

NCT06201598Cerebral Aneurysm, Thromboembolic Disease

Hospital Universitario Central de Asturias

Observational

100

A Coruña, Badalona, Barcelona, Burgos, Donostia / San Sebastian, Madrid, Málaga, Oviedo

2024-01-12

Recruiting

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

NCT06149286Relapsed/Refractory Follicular Lymphoma, Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL)

DrugsOdronextamab·Lenalidomide·Rituximab

Regeneron Pharmaceuticals

Phase 3

580

Santiago de Compostela, Palma, L'Hospitalet de Llobregat, Santander, Pozuelo de Alarcón, Oviedo, Barcelona, Granada

2023-12-28

Active, closed

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment

NCT05828511Multiple Myeloma

DrugLinvoseltamab

Regeneron Pharmaceuticals

Phase 1/2

148

Badalona, Pozuelo de Alarcón, Pamplona, Oviedo, Alicante, Barcelona, Madrid, Salamanca

2023-12-19

Active, closed

A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib

NCT05734105GIST

DrugsRipretinib·Sunitinib

Deciphera Pharmaceuticals, LLC

Phase 3

Barcelona, Vigo, Valencia, Madrid, Oviedo, Seville

2023-12-13

Active, closed

Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults and Adolescents on Top of Insulin Therapy (FABULINUS)

NCT06111586Type 1 Diabetes Mellitus

DrugFrexalimab

Sanofi

Phase 2

197

Barcelona, Esplugues de Llobregat, Oviedo, Seville, Málaga, Valencia, Vitoria-Gasteiz

2023-12-11

Active, closed

MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

NCT06132256Idiopathic Pulmonary Fibrosis

DrugAxatilimab

Syndax Pharmaceuticals

Phase 2

145

L'Hospitalet de Llobregat, Sabadell, Santander, Majadahonda, Oviedo, Barcelona, Cadiz, Girona

2023-12-11

Active, closed

A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy

NCT05988073Multifocal Motor Neuropathy

argenx

Observational

413

Alicante, Badalona, Barcelona, Bilbao, L'Hospitalet de Llobregat, Oviedo, Pamplona, San Sebastián

2023-11-29

Active, closed

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma

NCT06097364Follicular Lymphoma (FL)

DrugsOdronextamab·Prednisone/Prednisolone·Adriamycin·Cytoxan

Regeneron Pharmaceuticals

Phase 3

733

Seville, Sabadell, Terrassa, Barakaldo, Majadahonda, Pozuelo de Alarcón, Pamplona, Oviedo

2023-11-14

Active, closed

MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma

NCT06097728Unresectable Pleural Mesothelioma

DrugsVolrustomig·Yervoy·Paraplatin·Ipilimumab

AstraZeneca

Phase 3

863

Barakaldo, Barcelona, Madrid, Oviedo

2023-11-09

Active, closed

TheraSphere With Durvalumab and Tremelimumab for HCC

NCT05063565Hepatocellular Carcinoma

Boston Scientific Corporation

Phase 2

100

Barcelona, Pamplona, Oviedo, Madrid, Valencia, Valladolid

2023-11-03

Recruiting

Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.

NCT05918302Neuroendocrine Tumors, Lung Neuroendocrine Neoplasm, Thymus Neoplasms

Drugs177Lu-edotreotide·Everolimus

Grupo Espanol de Tumores Neuroendocrinos

Phase 3

170

Seville, L'Hospitalet de Llobregat, Santiago de Compostela, Madrid, Oviedo, Valencia, Barcelona

2023-10-27

Active, closed

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

NCT06025578Progressive Pulmonary Fibrosis

DrugAdmilparant

Bristol-Myers Squibb

Phase 3

1,057

Badalona, Barcelona, Santander, Santiago de Compostela, Málaga, Madrid, Majadahonda, Oviedo

2023-10-25

Active, closed

ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions

NCT05949684Myelodysplastic Syndromes

DrugsEpoetin Alfa·Reblozyl·Luspatercept

Bristol-Myers Squibb

Phase 3

402

Barcelona, L'Hospitalet de Llobregat, Valencia, Granada, Madrid, Oviedo, Salamanca, Seville

2023-10-24

Active, closed

A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

NCT05968326Adenocarcinoma, Pancreatic Ductal

DrugsAutogene cevumeran·MFOLFIRINOX·Tecentriq·Atezolizumab

Genentech, Inc.

Phase 2

260

Badalona, Málaga, Pamplona/iruña, Oviedo, Barcelona, Madrid

2023-10-18

Active, closed

MS-DETECT: Early Detection of Multiple Sclerosis Progression With MSCopilot® Detect

NCT05816122Multiple Sclerosis

Ad scientiam

Not applicable

336

Girona, Madrid, Málaga, Oviedo, Zaragoza

2023-09-22

Active, closed

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

NCT06003426Idiopathic Pulmonary Fibrosis

DrugAdmilparant

Bristol-Myers Squibb

Phase 3

1,255

Santander, Santiago de Compostela, Madrid, Majadahonda, Barcelona, Girona, Oviedo, Pamplona

2023-09-14

Active, closed

A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152)

NCT05904886Hepatocellular Carcinoma

DrugsTiragolumab·Tecentriq·Avastin·Atezolizumab

Hoffmann-La Roche

Phase 3

687

Navarra, Pamplona/iruña, Oviedo, Barcelona, Jaén, Madrid, Valencia

2023-09-14

Recruiting

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

NCT05722938Community-acquired Pneumonia

Biotest

Phase 3

590

Palma de Mallorca, Sabadell, Terrassa, Córdoba, Majadahonda, Pamplona, Oviedo, Barcelona

2023-09-09

Recruiting

Study of Personalized Allocation of Defibrillators in Non-ischemic Heart Failure (SPANISH-1)

NCT06055504Non-ischemic Dilated Cardiomyopathy

Consorcio Centro de Investigación Biomédica en Red (CIBER)

Not applicable

900

Santiago de Compostela, L'Hospitalet de Llobregat, Sabadell, A Coruña, Majadahonda, Oviedo, Alicante, Barcelona

2023-09-06

Recruiting

The ReTAVI Prospective Observational Registry

NCT05601453Structural Valve Deterioration, Structural Valve Degeneration, Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure, Prosthetic Valve Malfunction

Institut für Pharmakologie und Präventive Medizin

Observational

250

Barcelona, León, Madrid, Oviedo, Vigo

2023-09-05

Active, closed

A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder

NCT06021522Tourette Syndrome

Emalex Biosciences Inc.

Phase 3

150

Madrid, Oviedo, Seville

2023-08-16

Recruiting

Pivotal Study of the Vienna Transcatheter Self Expandable Aortic Valve SE System

NCT04861805Symptomatic Aortic Stenosis

P+F Products + Features GmbH

Not applicable

267

Barcelona, Madrid, Valladolid, Majadahonda, Málaga, Oviedo

2023-07-03

Active, closed

A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT05785767Advanced Non-Small Cell Lung Cancer

DrugsFianlimab·Cemiplimab

Regeneron Pharmaceuticals

Phase 2/3

149

Santiago de Compostela, Palma, Barcelona, Majadahonda, Oviedo, Madrid, Málaga, Seville

2023-06-30

Active, closed

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

NCT05827016Multiple Myeloma

DrugsIberdomide·Lenalidomide

Bristol-Myers Squibb

Phase 3

1,230

Barcelona, Cáceres, Las Palmas de Gran Canaria, Murcia, Oviedo, Valencia, Badalona, Madrid

2023-06-22

Recruiting

Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer

NCT06889883Colorectal Carcinoma, Advanced Adenomas (AA)

ADVANCED MARKER DISCOVERY S.L.

Observational

510

Zaragoza, Bilbao, Donostia / San Sebastian, Santander, Salamanca, Barcelona, Madrid, Oviedo

2023-06-06

Recruiting

Usefulness of PET-CT for Invasive Fungal Infection

NCT05688592Invasive Fungal Infections

Puerta de Hierro University Hospital

Observational

224

Majadahonda, Barcelona, Granada, Madrid, Málaga, Murcia, Oviedo, Salamanca

2023-04-27

Recruiting

Observational Cross-reactivity Study for Colorectal Cancer Diagnosis

NCT06889844Colorectal Cancer

ADVANCED MARKER DISCOVERY S.L.

Observational

250

Málaga, Oviedo, Ourense, Madrid

2023-04-17

Active, closed

Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation

NCT05758909Aortic Valve Disease, Aortic Valve Stenosis, Heart Valve Diseases

Fundación EPIC

Observational

585

A Coruña, Alicante, Aravaca, Badalona, Barcelona, L'Hospitalet de Llobregat, Málaga, Oviedo

2023-04-04

Active, closed

A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma

NCT05572515Multiple Myeloma

DrugsTeclistamab·Carfilzomib·Pomalidomide·Bortezomib

Janssen Research & Development, LLC

Phase 3

614

Badalona, Jerez de la Frontera, L'Hospitalet de Llobregat, León, Madrid, Murcia, Oviedo, Palma de Mallorca

2023-03-29

Recruiting

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

NCT05682378Heterozygous or Homozygous Familial Hypercholesterolemia

DrugInclisiran

Novartis Pharmaceuticals

Phase 3

195

Pamplona, Oviedo, A Coruña, Córdoba

2023-02-10

Recruiting

Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial

NCT05496998Mitral Regurgitation

Medtronic Cardiovascular

Not applicable

400

Barcelona, Madrid, Oviedo, Vigo

2023-02-07

Recruiting

Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units

NCT05686850Post Extubation Respiratory Failure

Poitiers University Hospital

Not applicable

670

Barcelona, L'Hospitalet de Llobregat, Oviedo, Toledo

2023-02-02

Active, closed

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

NCT05608291Melanoma

DrugsFianlimab·Cemiplimab·Keytruda·Pembrolizumab

Regeneron Pharmaceuticals

Phase 3

1,564

Badalona, Santander, Barcelona, Oviedo, Granada, Lugo, Madrid, Seville

2023-01-16

Active, closed

Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma

NCT05678673Non-Clear Cell Renal Cell Carcinoma

DrugsSunitinib Malate·Zanzalintinib·Sunitinib·Opdivo

Exelixis

Phase 3

317

Palma de Mallorca, Majadahonda, Barcelona, Córdoba, Girona, Madrid, Málaga, Oviedo

2023-01-01

Recruiting

Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.

NCT03994471End Stage Renal Disease

Iperboreal Pharma Srl

Phase 3

170

A Coruña, Badalona, Barcelona, Girona, Madrid, Oviedo

2022-12-14

Active, closed

A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)

NCT05469737Myelodysplastic Syndromes

DrugAzacitidine

Bristol-Myers Squibb

Phase 2/3

230

Valencia, Granada, Madrid, Ourense, Oviedo, Salamanca

2022-12-14

Active, closed

Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

NCT05570058IPF, Fibrosis

Redx Pharma Ltd

Phase 2

Barcelona, Madrid, Oviedo, Santander, Santiago de Compostela

2022-09-08

By invitation

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

NCT04905693Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Progressive Pulmonary Fibrosis

DrugTreprostinil

United Therapeutics

Phase 3

1,850

Santiago de Compostela, Palma de Mallorca, L'Hospitalet de Llobregat, Málaga, Oviedo, Barcelona, Granada, Madrid

2022-09-06

Recruiting

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

NCT05489705Obstructive Hypertrophic Cardiomyopathy

DrugMavacamten

Bristol-Myers Squibb

Observational

1,700

Palma de Mallorca, Majadahonda, El Palmar, Oviedo, Burgos, Madrid, Málaga

2022-08-16

Recruiting

Perpetual Observational Study - Ventilator Associated Pneumonia

NCT05719259Ventilator Associated Pneumonia

European Clinical Research Alliance for Infectious Diseases (ECRAID)

Observational

20,000

Córdoba, Oviedo, Burjassot, Barcelona

2022-08-03

Active, closed

Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma

NCT05352672Melanoma

DrugsFianlimab·Cemiplimab·Keytruda·Pembrolizumab

Regeneron Pharmaceuticals

Phase 3

1,546

Córdoba, Badalona, Barcelona, Donostia / San Sebastian, El Palmar, Oviedo, A Coruña, Girona

2022-07-14

Recruiting

Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery

NCT04918173Congenital Antithrombin Deficiency

Octapharma

Phase 3

Oviedo, Madrid, Murcia, Ourense

2022-07-01

Active, closed

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT04975997Multiple Myeloma

DrugsIberdomide·Bortezomib·Daratumumab·Dexamethasone

Celgene

Phase 3

939

Pamplona, Barcelona, Cáceres, Córdoba, Madrid, Málaga, Murcia, Oviedo

2022-06-23

Recruiting

Spanish Academy of Dermatology and Venereology (AEDV) Melanoma Registry

NCT05673681Melanoma

Fundación Academia Española de Dermatología

Observational

7,000

Badalona, A Coruña, Barcelona, Córdoba, Las Palmas, León, Madrid, Oviedo

2022-06-01

Active, closed

Active Lifestyle Intervention in Anorexia Nervosa: a Comprehensive Study

NCT06866301Anorexia Nervosa

University of Oviedo

Not applicable

Oviedo

2022-05-25

Active, closed

IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

NCT05155254Metastatic Melanoma, Unresectable Melanoma

DrugsIO102-IO103·Pembrolizumab

IO Biotech

Phase 3

407

Seville, A Coruña, Barcelona, Madrid, Málaga, Oviedo, Pamplona, Valencia

2022-05-17

Recruiting

Skeletal Muscle-derived Cell Implantation for Treatment of Fecal Incontinence

NCT04976153Fecal Incontinence

Innovacell GmbH

Phase 3

290

Barcelona, Mataró, Murcia, Oviedo

2022-05-11

Active, closed

Efficacy and Feasibility of an eHealth Intervention for Pregnant Women on Diet, Physical Activity and Knowledge Related to Pregnancy

NCT05424237Pregnancy Related

University of Oviedo

Not applicable

153

Oviedo

2022-05-01

Recruiting

Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®

NCT05114850Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Insufficiency, Heart Failure

P+F Products + Features GmbH

Observational

450

Galdakao, Málaga, Barcelona, Córdoba, Lugo, Madrid, Oviedo, Salamanca

2022-04-20

Active, closed

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)

NCT05270668Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease

DrugTulisokibart

Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Phase 2

154

Barcelona, Madrid, Oviedo, Málaga, Valencia, Zaragoza

2022-03-29

Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

NCT04988555Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma, Myelodysplastic Syndromes

DrugsAzoles·Gilteritinib·Azacitidine·Venetoclax

Sumitomo Pharma America, Inc.

Phase 1/2

606

Albacete, Barcelona, Cáceres, Las Palmas, Madrid, Oviedo, Salamanca, Santander

2022-02-28

Active, closed

Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)

NCT05051033Mitral Valve Regurgitation

Annetine Gelijns

Not applicable

450

Palma de Mallorca, Vigo, Barcelona, Madrid, Oviedo

2022-02-21

Recruiting

Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer

NCT05183984Ovarian Cancer

DrugsBevacizumab-awwb·Niraparib

ARCAGY/ GINECO GROUP

Phase 2

390

A Coruña, Barcelona, Cáceres, El Palmar, Murcia, Jerez de la Frontera, Madrid, Málaga, Oviedo

2022-02-01

Active, closed

A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

NCT05081609Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor, Platinum-resistant Ovarian Cancer

DrugsTrastuzumab emtansine·Trastuzumab·Pembrolizumab

Ascendis Pharma Oncology Division A/S

Phase 1/2

320

Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, Murcia, Oviedo, Pamplona, Seville

2022-01-11

Active, closed

Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE

NCT04919226Neuroendocrine Tumors

DrugsFOLFOX (Folinic acid·Everolimus·Fluorouracil·Oxaliplatin

ITM Solucin GmbH

Phase 3

259

Barcelona, Madrid, Oviedo, Santiago de Compostela, Valencia

2021-12-21

Active, closed

Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide

NCT05060627Relapsed Multiple Myeloma

DrugsBelantamab mafodotin·Carfilzomib·Dexamethasone

PETHEMA Foundation

Phase 1/2

Badalona, Barcelona, L'Hospitalet de Llobregat, Madrid, Murcia, Oviedo, Palma de Mallorca, Pamplona

2021-12-20

Active, closed

Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.

NCT05038735Breast Cancer

DrugsAlpelisib·Fulvestrant

Novartis Pharmaceuticals

Phase 3

210

Badajoz, Pozuelo de Alarcón, Oviedo, A Coruña, Barcelona, Madrid, Málaga, Zaragoza

2021-12-17

Active, closed

Assessment of Effectiveness and Safety of Luspatercept in Patients Suffering From Lower-risk Myelodysplastic Syndrome.

NCT05181592Myelodysplastic Syndromes

DrugsReblozyl·Luspatercept

GWT-TUD GmbH

Phase 3

Badalona, Barcelona, Madrid, Oviedo, Salamanca, Valencia

2021-10-27

Active, closed

A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET

NCT05050942Gastro-enteropancreatic Neuroendocrine Tumor

DrugsCAM2029·Octreotide LAR

Camurus AB

Phase 3

332

A Coruña, Barcelona, Elche, Girona, Madrid, Málaga, Murcia, Oviedo

2021-10-22

Active, closed

A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

NCT05023980Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

DrugsRiabni·Ruxience·Truxima·Pirtobrutinib

Loxo Oncology, Inc.

Phase 3

282

Madrid, Oviedo, Barcelona, Seville

2021-09-23

Active, closed

A Non-interventional Cohort Safety Study of Patients With hATTR-PN

NCT04850105Hereditary Transthyretin Amyloidosis With Polyneuropthy

Akcea Therapeutics

Observational

202

Huelva, Oviedo, Palma de Mallorca, Villarreal, Barcelona, Madrid

2021-09-21

Active, closed

A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

NCT04965493Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

DrugsRiabni·Ruxience·Truxima·Pirtobrutinib

Loxo Oncology, Inc.

Phase 3

600

Barcelona, Madrid, Majadahonda, Marbella, Oviedo, Pozuelo de Alarcón, Seville, Toledo

2021-09-20

Active, closed

A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

NCT04765059Non-small Cell Lung Cancer

DrugCarboplatin

AstraZeneca

Phase 3

Alicante, Barcelona, Córdoba, León, Madrid, Málaga, Murcia, Oviedo

2021-09-12

Active, closed

A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice

NCT05049798Arthritis, Psoriatic

DrugsIL-17i·Tremfya·Guselkumab

Janssen Pharmaceutica N.V., Belgium

Observational

1,314

A Coruña, Algeciras / Cadiz, Barcelona, Bilbao, Córdoba, Granada, Madrid, Oviedo

2021-08-25

Active, closed

Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)

NCT04976634Neoplasm Malignant

DrugsBelzutifan·Lenvatinib·Keytruda·Pembrolizumab

Merck Sharp & Dohme LLC

Phase 2

730

Badalona, Santiago de Compostela, Madrid, Oviedo, Barcelona

2021-08-18

Recruiting

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

NCT04924075Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease, Advanced Gastrointestinal Stromal Tumor

DrugBelzutifan

Merck Sharp & Dohme LLC

Phase 2

355

Madrid, Oviedo, Barcelona

2021-08-12

Active, closed

A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

NCT04657289Neovascular Age-related Macular Degeneration (nAMD)

DrugRanibizumab

Hoffmann-La Roche

Phase 3

451

L'Hospitalet de Llobregat, San Cugat Del Valles, Majadahonda, Pamplona, Oviedo, Barcelona, Córdoba, Madrid

2021-07-14

Recruiting

Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform

NCT04927156Intracranial Aneurysm, Brain Arterial Disease, Acute Ischemic Stroke, Peripheral Vascular Diseases

Balt Extrusion

Observational

10,000

Madrid, Oviedo, Santander, Zaragoza

2021-07-12

Active, closed

Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS

NCT05027984Coronary Artery Disease, Coronary Disease, Ischemic Heart Disease

Centro per la Lotta Contro l'Infarto - Fondazione Onlus

Not applicable

1,425

Málaga, Madrid, Oviedo

2021-06-30

Active, closed

Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008).

NCT04895722Colorectal Cancer

DrugsPembrolizumab/Vibostolimab·MK-4830·Pembrolizumab/Favezelimab·Pembrolizumab/Quavonlimab

Merck Sharp & Dohme LLC

Phase 2

302

Santander, Barcelona, Madrid, Málaga, Pamplona, Oviedo, Valencia

2021-06-25

Active, closed

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

NCT04821622Prostate Cancer

DrugsTalazoparib·Enzalutamide

Pfizer

Phase 3

599

Elche, Badalona, L'Hospitalet de Llobregat, Manresa, Lugo, Majadahonda, Pamplona, Oviedo

2021-05-12

Active, closed

Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-Eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)

NCT04700124Bladder Cancer

DrugsEnfortumab Vedotin·Platinol-AQ·Keytruda·Gemcitabine

Merck Sharp & Dohme LLC

Phase 3

808

Badalona, Manresa, Girona, Santiago de Compostela, Las Palmas de Gran Canaria, Oviedo, Valencia, Barcelona

2021-04-21

Active, closed

Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)

NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis

DrugsPelabresib·Ruxolitinib

Novartis Pharmaceuticals

Phase 3

430

Oviedo, Badalona, Barcelona, Cáceres, Las Palmas de Gran Canaria, Madrid, Murcia, Salamanca

2021-04-09

Active, closed

Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis

NCT04562389Myelofibrosis

DrugsSelinexor·Ruxolitinib

Karyopharm Therapeutics Inc

Phase 3

353

Cáceres, Oviedo, Zaragoza, Badalona, Barcelona, Girona, Las Palmas de Gran Canaria, Lugo

2021-03-11

Active, closed

Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

NCT04608318Chronic Lymphoid Leukemia

DrugsIbrutinib·Obinutuzumab·Venetoclax

German CLL Study Group

Phase 3

897

Badalona, Barcelona, Madrid, Málaga, Oviedo, Salamanca, Santander, Seville

2021-03-01

Active, closed

Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination With Venetoclax in Acute Myeloid Leukemia (AML)

NCT04657081Acute Myeloid Leukemia

DrugsDecitabine·Venclexta·Venetoclax

Taiho Oncology, Inc.

Phase 1/2

101

Oviedo, L'Hospitalet de Llobregat, Pamplona, Madrid, Salamanca, Valencia

2021-02-09

Active, closed

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

NCT04229979Acute Myeloid Leukemia

DrugsGm-Csf·Sargramostim·Ara-C·Decitabine

Sellas Life Sciences Group

Phase 3

127

Cáceres, Córdoba, Madrid, Oviedo, Pamplona, Salamanca, Seville, Valencia

2021-02-08

Active, closed

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

NCT04624204Small Cell Lung Cancer

DrugsOlaparib·Keytruda·Pembrolizumab

Merck Sharp & Dohme LLC

Phase 3

672

L'Hospitalet de Llobregat, Oviedo, Barcelona, Madrid, Málaga, Seville

2020-12-08

Active, closed

"Phase I / II Study on Infusion of Natural Killer Cells After Haploidentical Transplantation in Pediatric Patients"

NCT05304754High-risk Leukemias

Instituto de Investigación Hospital Universitario La Paz

Phase 1/2

Santiago de Compostela, Oviedo, Barcelona, Madrid, Málaga, Murcia, Seville, Valencia

2020-11-30

Active, closed

RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)

NCT04597125Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Bayer

Phase 4

654

Santiago de Compostela, Palma de Mallorca, Badalona, Castellon, Girona, Madrid, Majadahonda, Oviedo

2020-11-09

Active, closed

Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

NCT04446117Metastatic Prostate Cancer, Prostate Adenocarcinoma

DrugsZytiga·Xtandi·Abiraterone·Abiraterone acetate

Exelixis

Phase 3

575

Elche, Palma de Mallorca, Manresa, Santiago de Compostela, Alcorcón, Oviedo, Badalona, Barcelona

2020-10-19

Active, closed

Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

NCT04524611Crohn's Disease (CD)

DrugsSkyrizi·Risankizumab·Ustekinumab

AbbVie

Phase 3

527

Ferrol, Santiago de Compostela, Badalona, L'Hospitalet de Llobregat, Fuenlabrada, Majadahonda, Oviedo, Alicante

2020-09-30

Active, closed

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

NCT04468984Myelofibrosis (MF)

DrugsNavitoclax·Ruxolitinib

AbbVie

Phase 3

330

A Coruña, Santiago de Compostela, Badalona, Las Palmas de Gran Canaria, Oviedo, Barcelona, Granada, Madrid

2020-08-31

Active, closed

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

NCT04493853Hormone-Sensitive Prostate Cancer

DrugsZytiga·Capivasertib·Abiraterone acetate

AstraZeneca

Phase 3

1,012

Badalona (Barcelona), Barcelona, Las Palmas de Gran Canaria, Madrid, Oviedo, Santander, Seville

2020-07-13

Recruiting

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

NCT04256317Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm, Chronic Myelomonocytic Leukemia

DrugsVenclexta·Azacitidine·Venetoclax

Taiho Oncology, Inc.

Phase 2/3

316

Badalona, L'Hospitalet de Llobregat, Pamplona, Oviedo, Barcelona, Cáceres, Girona, Granada

2020-05-21

Recruiting

Terumo Aortic Global Endovascular Registry

NCT04246463Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Surgery

Vascutek Ltd.

Observational

1,000

Badalona, Barcelona, Oviedo

2019-12-17

Active, closed

A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma

NCT04194775Hepatocellular Carcinoma

DrugLenvatinib

CStone Pharmaceuticals

Phase 3

534

A Coruña, Ourense, Majadahonda, Oviedo, Ávila, Barcelona, Burgos, Girona

2019-12-13

Active, closed

Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock

NCT04055909Shock, Septic

Inotrem

Phase 2

355

Barcelona, Madrid, Oviedo, Terrassa, Valencia

2019-11-13

Active, closed

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors

NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors

DrugConcizumab

Novo Nordisk A/S

Phase 3

156

Madrid, Málaga, Oviedo, Seville, Valencia

2019-11-13

Active, closed

Safety and Efficacy of Silk Vista and Silk Vista Baby Flow Diverter for Intracranial Aneurysm Treatment

NCT04034810Intracranial Aneurysm, Flow Diverter

Balt Extrusion

Observational

234

Barakaldo, Madrid, Oviedo, Valladolid

2019-11-04

Recruiting

Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)

NCT04032470Essential Tremor

Boston Scientific Corporation

Observational

500

Barcelona, Oviedo

2019-10-23

Active, closed

Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors

NCT04083781Haemophilia A With Inhibitors, Haemophilia B With Inhibitors

DrugConcizumab

Novo Nordisk A/S

Phase 3

134

Barcelona, Madrid, Málaga, Oviedo, Seville

2019-10-21

Active, closed

Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations

NCT04006210Parkinson's Disease

NeuroDerm Ltd.

Phase 3

381

Oviedo, Alicante, Barcelona, Burgos, Madrid, Seville, Valencia

2019-09-30

Active, closed

Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer

NCT04186013Bladder Cancer

DrugsTecentriq·Atezolizumab

Spanish Oncology Genito-Urinary Group

Phase 2

Manresa, Sabadell, Reus, Granada, Lugo, Madrid, Ourense, Oviedo

2019-09-18

Active, closed

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

NCT04067336Advanced Malignant Neoplasm, Acute Myeloid Leukemia, Mixed Lineage Leukemia, Mixed Lineage Acute Leukemia

DrugsZiftomenib·Itraconazole·Midazolam

Kura Oncology, Inc.

Phase 1/2

263

Barcelona, Madrid, Oviedo, Seville, Valencia

2019-09-12

Recruiting

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis

DrugLuspatercept

Celgene

Phase 3

665

Barakaldo, Barcelona, Madrid, Oviedo, Salamanca, Seville, Valencia

2019-08-12

Active, closed

A Clinical Study on Acuris™ - Conometric Concept for Single Tooth Restoration

NCT04063878Jaw, Edentulous, Partially

Dentsply Sirona Implants and Consumables

Not applicable

160

Cheste, Oviedo

2019-07-30

Active, closed

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

NCT03937219Renal Cell Carcinoma

DrugsCabozantinib·Yervoy·Ipilimumab·Opdivo

Exelixis

Phase 3

855

Santiago de Compostela, Pamplona, Barcelona, Córdoba, Madrid, Oviedo, Valencia

2019-06-25

Active, closed

Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

NCT03992417Dermatitis Atopic

DrugDupilumab

Sanofi

Observational

955

Bilbao, Las Palmas de Gran Canaria, Majadahonda, Oviedo, Barakaldo, Barcelona, Madrid, Santiago de Compostela

2019-06-11

Recruiting

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT03850574Leukemia, Myeloid, Acute, Refractory AML, Relapsed Adult AML, Myelodysplastic Syndrome With Excess Blasts-2

DrugsAzacitidine·Venetoclax

Aptose Biosciences Inc.

Phase 1/2

240

Barcelona, Pozuelo de Alarcón, Oviedo, Valencia

2019-03-11

Active, closed

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

NCT03682536Myelodysplastic Syndromes

DrugsEpoetin Alfa·Luspatercept

Celgene

Phase 3

363

Barcelona, Granada, Madrid, Málaga, Murcia, Ourense, Oviedo, Palma de Mallorca

2019-01-02

Active, closed

Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels

NCT03720704Peripheral Vascular Diseases

W.L.Gore & Associates

Observational

280

Oviedo, Santiago de Compostela

2018-12-18

Active, closed

A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer

NCT03800134Non-Small Cell Lung Cancer

DrugsDurvalumab·Pemetrexed·Gemcitabine·Paclitaxel

AstraZeneca

Phase 3

825

Alicante, Barcelona, Donostia / San Sebastian, Madrid, Málaga, Oviedo, Pamplona, Santiago de Compostela (A Coruña)

2018-12-06

Active, closed

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

NCT03703297Small Cell Lung Cancer

DrugsTremelimumab·Durvalumab

AstraZeneca

Phase 3

730

Barcelona, Madrid, Oviedo, Seville, Valencia, Zaragoza

2018-09-27

Recruiting

Extension Study for the Port Delivery System With Ranibizumab (Portal)

NCT03683251Neovascular Age-Related Macular Degeneration

DrugPDS Implant with Ranibizumab

Hoffmann-La Roche

Phase 3

1,000

L'Hospitalet de Llobregat, San Cugat Del Valles, Majadahonda, Pamplona, Oviedo, Burjassot, Barcelona, Córdoba

2018-09-20

Active, closed

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

NCT03519945Ulcerative Colitis

DrugMirikizumab

Eli Lilly and Company

Phase 3

1,058

Alicante, Fuenlabrada, Girona, Huelva, Las Palmas de GC, Madrid, Oviedo, Sagunto

2018-07-18

Active, closed

SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma

NCT03589222Refractory Multiple Myeloma

DrugsSelinexor·Bortezomib·Daratumumab·Dexamethasone

PETHEMA Foundation

Phase 2

Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Murcia, Oviedo, Pamplona

2018-07-15

Active, closed

A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

NCT03574571Prostate Cancer

DrugsXofigo·Docetaxel

Memorial Sloan Kettering Cancer Center

Phase 3

732

Oviedo, Madrid, Barcelona, Castellon, Seville, Valencia

2018-06-19

Active, closed

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

NCT03522246Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer, Newly Diagnosed

DrugsRucaparib·Opdivo·Nivolumab

pharmaand GmbH

Phase 3

1,097

Barcelona, Bilbao, Castillón, El Palmar, Jerez de la Frontera, Madrid, Oviedo, Palma de Mallorca

2018-05-14

Active, closed

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

NCT03528694Non-muscle-invasive Bladder Cancer

DrugsBacillus Calmette-Guerin·Durvalumab

AstraZeneca

Phase 3

1,018

Badajoz, Barcelona, Elche(Alicante), Madrid, Málaga, Oviedo, Pamplona, Pozuelo de Alarcón

2018-05-14

Active, closed

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

NCT03466411Crohn's Disease

DrugsGuselkumab 1·Guselkumab 2·Guselkumab 3·Ustekinumab

Janssen Research & Development, LLC

Phase 2/3

1,409

Córdoba, Ferrol, Girona, Huelva, Madrid, Oviedo, Pontevedra, Seville

2018-04-13

Active, closed

Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma

NCT02984410Oropharyngeal Cancer, Supraglottic Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma

European Organisation for Research and Treatment of Cancer - EORTC

Not applicable

112

Barcelona, Madrid, Oviedo

2017-11-27

Active, closed

Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

NCT03298451Hepatocellular Carcinoma

DrugsSorafenib·Tremelimumab·Durvalumab

AstraZeneca

Phase 3

1,324

Barcelona, Madrid, Oviedo, Pamplona Madrid, Santander

2017-10-11

Recruiting

Registry for Patients With X-Linked Hypophosphatemia

NCT03193476X-Linked Hypophosphatemia

Kyowa Kirin Pharmaceutical Development Ltd

Observational

1,489

Barakaldo, Barcelona, Cartagena, El Palmar, Esplugues de Llobregat, Las Palmas de Gran Canaria, Madrid, Oviedo

2017-09-12

Active, closed

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer

DrugsCabozantinib·Tecentriq·Atezolizumab

Exelixis

Phase 1

914

Santiago de Compostela, Elche, Palma de Mallorca, Badalona, Sabadell, Jeréz de La Frontera, Pamplona, Oviedo

2017-09-05

Active, closed

Prevention of Incisional Hernia With an Onlay Mesh Visible on MRI

NCT03105895Incisional Hernia

Henares University Hospital

Observational

200

Arganda, Avilés, Oviedo, Talavera de la Reina, Madrid

2017-09-01

Recruiting

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

NCT03151629Prostate Cancer

Prostate Cancer Clinical Trials Consortium

Observational

5,000

Barcelona, Málaga, Valencia, Badalona, Castellon, Madrid, Oviedo, Zaragoza

2017-07-21

Active, closed

Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

NCT03049189Neuroendocrine Tumors

Drugs177Lu-DOTATOC·Everolimus

ITM Solucin GmbH

Phase 3

324

Barcelona, Madrid, Oviedo, Valencia

2017-02-02

Recruiting

Neurovascular Product Surveillance Registry

NCT02988128Intracranial Aneurysm, Stroke, Ischemic

Medtronic Neurovascular Clinical Affairs

Observational

4,000

Barakaldo, Barcelona, Madrid, Oviedo, San Sebastián, Seville, Valladolid, Vigo

2016-12

Active, closed

Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

NCT02811861Renal Cell Carcinoma

DrugsSunitinib·Everolimus·Lenvatinib·Pembrolizumab

Eisai Inc.

Phase 3

1,069

Santander, Barcelona, Cáceres, Córdoba, Madrid, Oviedo, Seville, Valencia

2016-10-13

Recruiting

Vercise™ DBS Dystonia Prospective Study

NCT02686125Dystonia

Boston Scientific Corporation

Observational

300

Barcelona, El Palmar, Madrid, Oviedo

2016-03-07

Active, closed

Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma

NCT02415413Smoldering Multiple Myeloma

DrugsMelphalan·Carfilzomib·Lenalidomide·Dexamethasone

PETHEMA Foundation

Phase 2

Barcelona, Madrid, Murcia, Oviedo, Pamplona, Plama de Mallorca, Salamanca, Santa Cruz de Tenerife

2015-05

Active, closed

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

NCT02308085Early Breast Cancer

ETOP IBCSG Partners Foundation

Not applicable

518

El Palmar, Barcelona, Donostia / San Sebastian, Girona, Madrid, Málaga, Oviedo, Palma

2014-12-04

Recruiting

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

NCT02071134Parkinson's Disease

Boston Scientific Corporation

Observational

1,500

Barcelona, Madrid, Murcia, Oviedo, Valencia

2014-03-04

Recruiting

Lysosomal Acid Lipase (LAL) Deficiency Registry

NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2

Alexion Pharmaceuticals, Inc.

Observational

300

Santiago de Compostela, Barakaldo, Logroño, Burela de Cabo, Málaga, Oviedo, Reus, A Coruña

2013-05-30

Recruiting

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

NCT01949129Acute Lymphoblastic Leukaemia

DrugsGrafalon·Treosulfan·Thiotepa·Busulfan

St. Anna Kinderkrebsforschung

Phase 2/3

1,800

Barcelona, Málaga, Murcia, Oviedo

2013-04

Active, closed

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

NCT01586910Severe Aortic Stenosis

Medtronic Cardiovascular

Not applicable

1,746

Málaga, Oviedo

2012-04

Recruiting

Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)

NCT06911099Atrial Functional Mitral Regurgitation, Mitral Insufficiency

University Hospital of Cologne

Observational

1,000

Barcelona, Córdoba, León, Oviedo, Vigo

2010-01-01

Active, closed

Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

NCT00099437Breast Cancer

DrugFulvestrant

AstraZeneca

Phase 3

736

A Coruña, Madrid, Málaga, Oviedo, Salamanca, Seville

2005-02-13

Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-spain/city/oviedo

Query this register directly

GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,882 studies in total at the last sync on 10 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 235 of those studies with a site in Oviedo.

How many clinical trials are recruiting in Oviedo?

102 of the 235 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:19 UTC sync. A further 14 have not yet opened recruitment, 116 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Oviedo), 235 studies
Phase	Studies	Recruiting	Share
Phase 3	100	34	42.6%
Observational	50	30	21.3%
Phase 2	32	12	13.6%
Not applicable	25	11	10.6%
Phase 1/2	11	4	4.7%
Phase 2/3	10	7	4.3%
Phase 4	4	3	1.7%
Phase 1	2	1	0.9%
Early Phase 1	1	0	0.4%

Most active sponsors

Lead sponsors with the most studies (Oviedo)
Lead sponsor	Studies	Recruiting
AstraZeneca	15	6
Merck Sharp & Dohme LLC	11	5
University of Oviedo	11	1
Regeneron Pharmaceuticals	8	2
Bristol-Myers Squibb	7	1
Eli Lilly and Company	6	4
Exelixis	5	1
GlaxoSmithKline	5	4
Investigación en Hemofilia y Fisioterapia	5	2
Sanofi	5	1

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.